[-] Show simple item record

dc.contributor.authorGerayli, Fereshteh
dc.contributor.authorLoven, Bridget
dc.date.issued2007-02eng
dc.description.abstractThe use of inhaled corticosteroids at conventional doses for asthma and chronic obstructive pulmonary disease (COPD) does not appear to be associated with significant bone loss at 2 to 3 years of follow-up (strength of recommendation [SOR]: A, systematic reviews and randomized controlled trials [RCTs]). However, higher doses of inhaled corticosteroids may be associated with negative bone density changes at up to 4 years of follow-up (SOR: C, RCTs without change in fracture rates). No evidence exists to evaluate whether nasal steroids increase the risks of bone loss. Longer-term effects of prolonged use of inhaled steroids on BMD or fracture risk are undetermined with current evidence.en
dc.identifier.citationJournal of Family Practice, 56(2) 2007: 131+.en
dc.identifier.urihttp://hdl.handle.net/10355/3609
dc.publisherFamily Physicians Inquiries Networken
dc.relation.ispartofClinical Inquiries, 2007 (MU)en
dc.relation.ispartofcommunityUniversity of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Network
dc.subjectbone lossen
dc.subjectfracture risken
dc.subjectbone mineral density (BMD)en
dc.subject.lcshAdrenocortical hormones -- Therapeutic use -- Side effectsen
dc.subject.lcshLungs -- Diseases, Obstructive -- Treatmenten
dc.subject.lcshOsteoporosisen
dc.titleDo inhaled steroids increase the risk of osteoporosis?en
dc.typeArticleen


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record